Headlands Technologies LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 41,824 shares of the conglomerate's stock, valued at approximately $9,601,000. Danaher comprises about 1.0% of Headlands Technologies LLC's investment portfolio, making the stock its 14th largest position.
Other institutional investors have also recently made changes to their positions in the company. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after buying an additional 2,202 shares in the last quarter. ORG Partners LLC grew its holdings in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd bought a new stake in Danaher in the fourth quarter worth $8,044,000. Stifel Financial Corp raised its stake in Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after purchasing an additional 11,216 shares in the last quarter. Finally, Compass Capital Management Inc. lifted its position in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock valued at $54,615,000 after purchasing an additional 10,994 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analyst Ratings Changes
DHR has been the topic of several recent research reports. Wells Fargo & Company decreased their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Royal Bank of Canada restated an "outperform" rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Scotiabank began coverage on shares of Danaher in a research note on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price objective for the company. Finally, The Goldman Sachs Group raised shares of Danaher from a "neutral" rating to a "buy" rating and set a $260.00 target price on the stock in a research note on Friday, March 21st. Five research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $278.24.
Get Our Latest Analysis on DHR
Danaher Stock Down 8.3 %
Shares of DHR traded down $16.49 during trading hours on Friday, hitting $181.42. The company had a trading volume of 7,117,117 shares, compared to its average volume of 3,229,595. The company has a market capitalization of $129.66 billion, a PE ratio of 34.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company's fifty day moving average price is $209.99 and its two-hundred day moving average price is $233.99. Danaher Co. has a one year low of $181.20 and a one year high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business posted $2.09 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Friday, March 28th. This is a boost from Danaher's previous quarterly dividend of $0.27. Danaher's payout ratio is 24.24%.
Insider Buying and Selling at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report